Announcements Trials
Browse Landscape

Status

Completed 504Unknown 187Recruiting 125Terminated 113Active not recruiting 55Not yet recruiting 49Withdrawn 39Suspended 5Enrolling by invitation 4Approved for marketing 2

Sponsor Class

OTHER 2

Study Type

Expanded_access 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Wounds and Injuries 1Pancreatic Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

gallium 68 PSMA-11 2Oxaliplatin 2Magnetic Resonance Spectroscopy 2Fluorouracil 2motexafin gadolinium 1glucarpidase 1Positron-Emission Tomography 1Leucovorin 1Laparoscopy 1Gemtuzumab 1Gadolinium 1Carboxypeptidases 1Amifampridine 13-Iodobenzylguanidine 12-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Approved for marketing × OTHER × Fluorouracil × Clear all
NCT02436044 2019-08-20

HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC

Sun Yat-sen University

Approved for marketing
Gastrointestinal

Carcinoma, Hepatocellular, Wounds and Injuries

NCT00786058 2009-06-15

A Phase III Second Line Trial in Advanced Pancreatic Cancer CONKO 003

CONKO-Studiengruppe

Approved for marketing
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡